Skip to content

Interventional therapy of bifurcation lesions: A flow-guided concept to treat side branches in bifurcation lesions - a prospective randomized clinical study (THUEringer BIfurcation Study, THUEBIS-Study)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN22637771
Enrollment
110
Registered
2008-02-14
Start date
2004-09-01
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary bifurcation lesion Circulatory System Coronary bifurcation lesion

Interventions

Complex vs simple PCI

Sponsors

Berka Clinic, Department of Cardiology (Zentralklinik Bad Berka, Klinik für Kardiologie) (Germany)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Male or female patients older than 18 years of age 2. Diagnosis of stable angina or silent ischemia 3. Presence of a de novo, true coronary bifurcation lesion, defined as stenosis >50% in both the Main Branch (MB) and the ostium of the Side Branch (SB). Both branches were required to have a Thrombolysis In Myocardial Infarction (TIMI) flow of at least 2 or 3 as well as a reference vessel size >2.25 mm by visual estimation or a relevant SB which the operator would not have wanted to loosen during the procedure. If two commensurate vessels were present, the main branch was defined as the largest of the two vessels involved.

Exclusion criteria

Exclusion criteria: 1. A myocardial infarction in the 24 hours preceding treatment (STEMI and NSTEMI) 2. Stenosis of the left main coronary artery unprotected by a graft 3. Cardiogenic shock 4. Angiographically visible thrombus within the target lesion, restenosis or total occlusion of the target lesion 5. Life expectancy <1 year 6. Suspected intolerance to paclitaxel, aspirin or clopidogrel

Design outcomes

Primary

MeasureTime frame
Target Lesion Revascularization (TLR) at 6 months

Secondary

MeasureTime frame
1. Incidence of binary restenosis >50% (MB) at 6 months 2. Calculated late-luminal loss evaluated by Quantitative Coronary Angiography (QCA) 6 months after PCI 3. Incidence of Target Vessel Revascularization (TVR) and Major Adverse Cardiac Events (MACE) at 6 months

Countries

Germany

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Apr 2, 2026